Literature DB >> 2039695

Lymphocyte targeted ricin as a potential therapy for lymphoid malignancy. I. Targeting efficiency.

C S Ramsden1, M T Drayson, E B Bell.   

Abstract

Lymphocytes were studied as vehicles to target the plant toxin ricin, to lymphoid tissue in rats. Ricin-loaded thoracic duct lymphocyte (TDL) migrated normally into lymph nodes (LN) at 0.5 h, but this process was arrested by 3 h after injection. Ricin was successfully targeted to lymphoid tissue as evidenced by a 4-fold increase in ricin-associated radioactivity in LN, a 10-fold increase in the Peyers patches, a doubling in the spleen and a 35% reduction of radioactivity in the liver compared with free ricin. Nevertheless this represented a considerable shortfall in the expected targeting efficiency. The main problem was found to be high in vivo elution of ricin from TDL (70% within 0.5 h of i.v injection). This and other aspects relevant to maximising targeting efficiency are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2039695      PMCID: PMC1972389          DOI: 10.1038/bjc.1991.158

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

1.  The toxicity, distribution and excretion of ricin holotoxin in rats.

Authors:  C S Ramsden; M T Drayson; E B Bell
Journal:  Toxicology       Date:  1989-04       Impact factor: 4.221

2.  Elimination of T cells from human peripheral blood and bone marrow using a cocktail of three anti-T cell immunotoxins.

Authors:  F E Katz; G Janossy; A Cumber; W Ross; H A Blacklock; W Tax; P E Thorpe
Journal:  Br J Haematol       Date:  1987-12       Impact factor: 6.998

3.  Preparation of antibody-toxin conjugates.

Authors:  A J Cumber; J A Forrester; B M Foxwell; W C Ross; P E Thorpe
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

4.  The carriage and delivery of substances to lymphatic tissues by recirculating lymphocytes. I. The concentration of ricin in lymphocyte traffic areas.

Authors:  S M Sparshott; J A Forrester; D P McIntosh; C Wood; A J Davies; W L Ford
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

5.  The rapid rejection of allogeneic lymphocytes by a non-adaptive, cell-mediated mechanism (NK activity).

Authors:  B Rolstad; S Fossum; H Bazin; I Kimber; J Marshall; S M Sparshott; W L Ford
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

6.  Exploiting lymphocyte traffic to deliver radioactivity or ricin to lymphatic tissues.

Authors:  W L Ford; A J Davies; M Birch; J A Forrester; D McIntosh; H Sharma; S Sparshott; C Wood
Journal:  Adv Exp Med Biol       Date:  1985       Impact factor: 2.622

7.  Evaluation of ricin A-chain immunotoxins directed against human T cells.

Authors:  O W Press; E S Vitetta; A G Farr; J A Hansen; P J Martin
Journal:  Cell Immunol       Date:  1986-10-01       Impact factor: 4.868

8.  The carriage and delivery of substances to lymphatic tissues by recirculating lymphocytes. II. Long-term selective irradiation of the spleen and lymph nodes by deposition of indium-114m.

Authors:  M Birch; H L Sharma; E B Bell; W L Ford
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

9.  The behavior of autologous indium-114m-labeled lymphocytes in patients with lymphoid cell malignancy.

Authors:  D Hamilton; R A Cowan; H L Sharma; M Drayson; P M Nuttall; J Wagstaff; D P Deakin; D Crowther
Journal:  J Nucl Med       Date:  1988-04       Impact factor: 10.057

10.  Temporary inhibition of Moloney-murine sarcoma virus (M-MSV) induced-tumours by adoptive transfer of ricin-treated T-lymphocytes.

Authors:  V Cerundolo; P Zanovello; D McIntosh; R Fabbris; A J Davies; D Collavo
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.